Affordable Access

deepdyve-link
Publisher Website

COVID-19 trials in Italy: A call for simplicity, top standards and global pooling.

Authors
  • Maggioni, Aldo P1
  • Andreotti, Felicita2
  • Gervasoni, Cristina3
  • Di Pasquale, Giuseppe4
  • 1 ANMCO Research Center, Florence, Italy. Electronic address: [email protected] , (Italy)
  • 2 Physician Scientist, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. , (Italy)
  • 3 Department of Infectious Diseases Physician, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy. , (Italy)
  • 4 Local Health Authority, Bologna, Italy. , (Italy)
Type
Published Article
Journal
International journal of cardiology
Publication Date
Nov 01, 2020
Volume
318
Pages
160–164
Identifiers
DOI: 10.1016/j.ijcard.2020.06.043
PMID: 32610153
Source
Medline
Language
English
License
Unknown

Abstract

The novel coronavirus disease, affecting ~9 million people in the past five months and causing >460,000 deaths worldwide, is completely new to mankind. More than 2,000 research projects registered at ClinTrials.gov are aiming at finding effective treatments for rapid transfer to clinical practice. Unfortunately, just few studies have a sufficiently valid design to provide reliable information for clinical practice. Copyright © 2020 Elsevier B.V. All rights reserved.

Report this publication

Statistics

Seen <100 times